Hypertension: Update 2012

Abstract

Since January 1, 2012, a new team of editors has been looking after the journal. The photographs with a very brief summary of research interests are being used here as an introduction for all of our readers (Figure). We are privileged to be able to serve the readers of Hypertension and to follow in the footsteps of an excellent editorial team led by Dr John Hall.1 Indeed, we suspect that you haven't noticed the transition, because our aim has been to make it as smooth as possible. Figure. A , Editor-in-Chief Anna F. Dominiczak, OBE, MD, FRCP, FRSE, FAHA, FMedSci; University of Glasgow, Glasgow, Scotland, United Kingdom; Regius Professor of Medicine and Vice Principal and Head of College of Medical, Veterinary, and Life Sciences at the University of Glasgow; honorary consultant physician with the Greater Glasgow and Clyde Health Board. Prof Dominiczak's major research interests are in clinical and experimental hypertension, cardiovascular genomics, biomarkers, and systems medicine. B , Deputy Editor Rhian Touyz, MBBCh, MSc(Med), PhD; University of Glasgow, Glasgow, Scotland, United Kingdom; Director of the Institute of Cardiovascular and Medical Sciences, British Heart Foundation Glasgow Cardiovascular Research Centre at Glasgow University; Chair of the Council for High Blood Pressure Research of the American Heart Association. Dr Touyz's areas of study include clinical and experimental hypertension, signal transduction, oxidative stress, ion transport, cell biology, vascular biology, adipose tissue biology, and diabetes. She has a particular interest in translational research. Associate Editors: C , Gregory Fink, PhD; Michigan State University, East Lansing, MI; Professor, Department of …